In St. Louis alone, local hospitals reported hundreds of brain injury-related ER visits in 2023, many stemming from car crashes, falls, and workplace incidents. Taking the proper legal steps early on is critical when facing a TBI.

This post outlines why timely legal representation makes all the difference for brain injury victims in St. Louis.

Explaining Brain Injuries

In some cases, the effects are long-term, impairing an individual from working, socializing, and performing even the most basic daily activities.

Recognizing the Signs

Why Legal Help Is Important

Getting Legal Help

Also, if the insurance company does not make a reasonable offer to settle the claim, it may become necessary to obtain court intervention. Attorneys can bargain for the injured and ensure the harmed person obtains genuine compensation. If there are any questions regarding fault or the injury's extent, timely legal assistance is also vital.

Choosing the Right Lawyer

Preparing for the First Consultation

Discussing the potential outcomes and timelines during the consultation is also necessary. Being clear on potential legal fees and how they are charged can also help avoid misunderstandings in the future. This process allows the injured individual to learn how to move forward.

The Legal Process: What to Expect

It is essential to be patient during this lengthy process and rest assured that your legal representative is taking all appropriate actions. During this time, the client must hear from the lawyer and be updated.

Conclusion

]]> Fri, 23 MAY 2025 02:09:30 AEST New York (AFP) May 4, 2025 - Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

]]> Fri, 23 MAY 2025 02:09:30 AEST Los Angeles CA (SPX) Apr 23, 2025 - Redwire Corporation (NYSE: RDW), a prominent force in space infrastructure innovation, has expanded its pharmaceutical research efforts in orbit with the deployment of new crystallization technology and a groundbreaking cancer-detection experiment aboard the International Space Station (ISS).

Building on the success of its PIL-BOX platform, Redwire has introduced a high-volume Industrial Crystallizer designed to process samples up to 200 times larger than those previously accommodated. This advancement supports the company's vision of scaling in-space drug development into commercially viable production. The goal is to convert microgravity-based insights into manufacturable materials that serve terrestrial medical and industrial markets.

A key component of the expansion is the "Golden Balls" experiment, which aims to create gold nanospheres in microgravity for the first time. These nanoparticles have potential uses in medical diagnostics and targeted cancer therapies. Redwire expects space-grown nanospheres to exhibit enhanced size uniformity and surface integrity, attributes that could improve their effectiveness in biomedical applications.

"Gold nanospheres could lead to early testing and diagnosis of cancer and other diseases, targeted drug delivery, and enhanced radiation and photothermal therapy, offering a promising approach to cancer management," said John Vellinger, Redwire's President of In-Space Industries.

The new Industrial Crystallizer and the Golden Balls experiment were launched aboard SpaceX's 32nd commercial resupply mission to the ISS on April 21st.

]]> Fri, 23 MAY 2025 02:09:30 AEST Washington (AFP) April 20, 2025 - Cake, gifts and a low-key family celebration may be how many senior citizens picture their 70th birthday.

But NASA's oldest serving astronaut Don Pettit became a septuagenarian while hurtling towards the Earth in a spacecraft to wrap up a seven-month mission aboard the International Space Station (ISS).

A Soyuz capsule carrying the American and two Russian cosmonauts landed in Kazakhstan on Sunday, the day of Pettit's milestone birthday.

"Today at 0420 Moscow time (0120 GMT), the Soyuz MS-26 landing craft with Alexei Ovchinin, Ivan Vagner and Donald (Don) Pettit aboard landed near the Kazakh town of Zhezkazgan," Russia's space agency Roscosmos said.

Spending 220 days in space, Pettit and his crewmates Ovchinin and Vagner orbited the Earth 3,520 times and completed a journey of 93.3 million miles over the course of their mission.

It was the fourth spaceflight for Pettit, who has logged more than 18 months in orbit throughout his 29-year career.

The trio touched down in a remote area southeast of Kazakhstan after undocking from the space station just over three hours earlier.

NASA images of the landing showed the small capsule parachuting down to Earth with the sunrise as a backdrop.

The astronauts gave thumbs-up gestures as rescuers carried them from the spacecraft to an inflatable medical tent.

Despite looking a little worse for wear as he was pulled from the vessel, Pettit was "doing well and in the range of what is expected for him following return to Earth," NASA said in a statement.

He was then set to fly to the Kazakh city of Karaganda before boarding a NASA plane to the agency's Johnson Space Center in Texas.

The astronauts spent their time on the ISS researching areas such as water sanitization technology, plant growth in various conditions and fire behavior in microgravity, NASA said.

The trio's seven-month trip was just short of the nine months that NASA astronauts Butch Wilmore and Suni Williams unexpectedly spent stuck on the orbital lab after the spacecraft they were testing suffered technical issues and was deemed unfit to fly them back to Earth.

Space is one of the final areas of US-Russia cooperation amid an almost complete breakdown in relations between Moscow and Washington over the Ukraine conflict.

bur-cms/tjx/pbt/giv

ISS A/S

]]> Fri, 23 MAY 2025 02:09:30 AEST Los Angeles CA (SPX) Apr 15, 2025 - Expedition 72 astronauts kicked off the week investigating how extended spaceflight alters human vision, while simultaneously conducting other scientific studies, maintaining vital systems, and preparing for an upcoming crew return.

Prolonged exposure to microgravity can impair vision, posing a potential risk to astronauts on long-duration missions to the Moon or Mars. NASA's CIPHER study, a comprehensive effort composed of 14 integrated human research experiments, is focused on understanding and mitigating the physical and psychological challenges of deep space travel. One aspect of CIPHER centers on how brain and eye structures shift during long stays aboard the International Space Station.

On Monday, NASA Flight Engineer Anne McClain conducted vision assessments on fellow NASA astronaut Jonny Kim. The tests included retinal light response measurements using specialized eye drops and electrodes, followed by high-resolution imaging of Kim's retina, optic nerve, and cornea. The findings will help researchers develop better protective strategies for future deep-space crews.

McClain also collaborated with NASA Flight Engineer Nichole Ayers and JAXA Flight Engineer Takuya Onishi to inspect and service key components of U.S. spacesuits. McClain and Onishi checked the suit control panels that monitor system status during extravehicular activity. Onishi then teamed with Ayers to organize spacewalk tools in the Quest airlock, the main staging area for American spacewalks.

Meanwhile, Kim rehearsed procedures for monitoring the upcoming SpaceX Dragon cargo vehicle as it approaches for docking. His review included various approach scenarios to ensure mission success when the spacecraft delivers fresh supplies and science payloads later this month.

With their mission nearing completion, NASA's Don Pettit, Roscosmos Commander Alexey Ovchinin, and Flight Engineer Ivan Vagner are preparing to leave the station. The trio is scheduled to depart aboard Soyuz MS-26 at 5:57 p.m. EDT on April 19, with a landing expected in Kazakhstan at 9:20 p.m. EDT (6:20 a.m. local time on May 20). In anticipation of their return, Ovchinin and Vagner evaluated lower body negative pressure suits, which are designed to ease the body's re-adaptation to Earth gravity. Pettit spent part of the day packing his gear and servicing scientific equipment.

Cosmonauts Sergey Ryzhikov and Alexey Zubritsky, newly arrived along with Kim, focused on cardiovascular adaptation research. Using sensors on their heads, fingers, and toes, the duo measured blood distribution in microgravity. Flight Engineer Kirill Peskov assisted Ovchinin and Vagner with their suit evaluations and later sanitized surfaces in the Nauka module.

]]> Fri, 23 MAY 2025 02:09:30 AEST Sydney, Australia (SPX) Apr 15, 2025 - As human space missions extend in duration and complexity, maintaining astronaut health has become a top priority. A recent review in Wearable Electronics explores how flexible wearable technologies are emerging as vital tools in aerospace medicine, offering continuous, real-time health monitoring in the demanding environment of space.

These adaptable devices are built with integrated sensor systems capable of tracking a wide array of physiological and psychological indicators. From biosignal electrodes that monitor cardiac activity to inertial measurement units assessing balance and muscle function, flexible wearables provide essential early warnings for issues related to the heart, muscles, or sleep-wake cycles. Environmental sensors embedded in the wearables further enhance safety by detecting changes in surrounding space conditions.

Despite these advantages, the deployment of wearables in orbit still faces significant engineering challenges. Key issues include ensuring that devices maintain accuracy and durability under microgravity, radiation, and severe thermal variations. Another major concern is protecting sensitive medical data within the confines of spacecraft, where privacy and security systems must be carefully managed. Additionally, interpreting the complex data streams produced by these devices demands advanced algorithms capable of synchronizing diverse biological signals across both time and space.

To overcome these hurdles, future innovations are expected to arise from cross-disciplinary efforts. Progress in material science will drive the development of more robust and adaptive components, while intelligent data-processing algorithms will improve both the interpretation and responsiveness of wearable systems. Device integration strategies will also be critical to ensuring seamless, user-friendly operation in zero-gravity environments.

The review underscores that continued advancement in flexible electronics, combined with deeper collaboration among engineers, biomedical researchers, and space agencies, will play a pivotal role in safeguarding astronaut health. As wearable technology matures, it promises to become a cornerstone of medical care for long-duration missions, helping to ensure both crew safety and mission success.

Research Report:Flexible wearable device applications for monitoring astronaut health: Current status and challenges

]]> Fri, 23 MAY 2025 02:09:30 AEST Los Angeles CA (SPX) Apr 14, 2025 - The Expedition 72 team aboard the International Space Station (ISS) closed out their week with a focus on spacesuit enhancements and critical biomedical research. As one group adjusted to the rigors of microgravity, another prepared for their journey home after months in orbit.

NASA astronauts Anne McClain and Nichole Ayers spent Friday outfitting two spacesuits with newly installed display and control modules inside the station's Quest airlock. The updated liquid crystal electronics provide real-time suit diagnostics, ensuring astronauts have clear data on suit performance during extravehicular activity. Concurrently, crewmates Jonny Kim and Don Pettit conducted a comprehensive review of suit readiness protocols and hardware configurations.

Having arrived on April 8 aboard Soyuz MS-27, Kim is acclimating to life aboard the ISS alongside Roscosmos cosmonauts Sergey Ryzhikov and Alexey Zubritsky. Despite their short time on station, the trio has already begun routine maintenance and scientific duties. On Friday, Kim focused on orbital plumbing tasks in the Tranquility module, while Ryzhikov and Zubritsky participated in physiological experiments tracking respiratory patterns and circulatory responses in zero gravity. The duo used sensor arrays to monitor blood flow across various extremities and the forehead.

Pettit, who is nearing the end of his mission, has started transitioning responsibilities to the newer arrivals. He offered training on the use of the advanced resistive exercise device, a cornerstone for maintaining muscle and bone health in microgravity. Station Commander Alexey Ovchinin and Flight Engineer Ivan Vagner, who launched on September 11, 2024, are rehearsing descent techniques ahead of their planned April 19 return aboard Soyuz MS-26. The crew will depart from the Rassvet module and land in Kazakhstan, concluding Expedition 72.

Earlier in the day, Pettit also contributed to a student-designed experiment, analyzing the melting behavior of frozen droplets made from water, salt solutions, and olive oil in the unique environment of space. He later performed ultrasound scans of JAXA astronaut Takuya Onishi, focusing on vascular changes in the neck, shoulder, and legs to better understand how the body adapts to prolonged weightlessness.

Elsewhere, Ovchinin and Vagner joined Roscosmos Flight Engineer Kirill Peskov to test a lower body negative pressure suit. This device is designed to simulate gravitational effects by drawing fluids toward the lower body, potentially alleviating intracranial pressure and easing the return to Earth's gravity.

]]> Fri, 23 MAY 2025 02:09:30 AEST Los Angeles CA (SPX) Apr 02, 2025 - Expedition 72 astronauts kicked off the week by strapping on wearable sensors and engaging in workout regimens designed to help researchers understand how the human body adjusts to spaceflight. These investigations not only monitor health but also shape future countermeasures for long-duration missions in microgravity.

NASA Flight Engineer Nichole Ayers wore a biometric vest and headband outfitted with sensors for a continuous 48-hour cardiovascular health study. The real-time data, captured on a tablet, is part of the Space Health experiment aimed at enhancing remote medical support for space crews far from Earth.

Meanwhile, JAXA astronaut Takuya Onishi took part in a biomechanics study known as ARED Kinematics. Wearing reflective markers on his legs, Onishi exercised on the advanced resistive exercise device (ARED), which simulates free weights. The study helps physicians analyze how space-based workouts influence musculoskeletal health.

Roscosmos cosmonauts Alexey Ovchinin and Ivan Vagner wrapped up a weeklong circulatory system experiment. By placing sensors on their foreheads, fingers, and toes, they documented how blood redistributes from the upper body to the extremities in a microgravity environment.

Elsewhere on the orbital platform, NASA astronauts Don Pettit and Anne McClain removed materials from the Microgravity Science Glovebox. The hardware was previously used to investigate particle transport across thermal boundaries and refine methods for separating viruses from fluids, with applications in disease diagnostics.

Roscosmos Flight Engineer Kirin Peskov focused on station upkeep. He repaired a thermal sensor in the Zvezda module, tested electrical outputs of a compressor system, cleaned air vents, and facilitated water transfers between onboard tanks.

]]> Fri, 23 MAY 2025 02:09:30 AEST Los Angeles CA (SPX) Mar 30, 2025 - Heart disease is the top cause of death in the United States, responsible for one in every five fatalities. A key challenge lies in the heart's inability to regenerate damaged muscle tissue, often leaving patients with end-stage heart failure reliant on transplants. Seeking alternative treatments, researchers at Emory University have turned to an extraordinary environment for answers: the International Space Station (ISS).

Led by Chunhui Xu, the team utilized the ISS National Laboratory to explore how space-based conditions could improve regenerative therapies targeting heart damage. Their findings, featured in multiple peer-reviewed journals including a recent article in *Biomaterials*, suggest that microgravity may offer unique biological advantages for cardiac cell development. The full story of Xu's research is available in the latest issue of *Upward*, the ISS National Lab's magazine.

Xu's interest in space-based science was sparked by a seminar highlighting microgravity's unexpected influence on cancer cell behavior. Scientists had noted that cancer cells proliferated and survived at higher rates in space, prompting Xu to question whether heart cells might respond similarly. If true, this could address two major obstacles in developing cell-based treatments for heart disease: efficient cell growth and survival.

Initial tests using simulated microgravity yielded promising results, paving the way for two subsequent investigations aboard the ISS. The first mission studied how stem cells transform into heart muscle cells, while the second focused on how these cells mature into more tissue-like structures. Together, these studies offer critical insights into improving the production and functionality of cardiac cells for therapeutic use.

"The space environment provides an amazing opportunity for us to study cells in new ways. Our research on the ISS could allow us to develop a new strategy to generate cardiac cells more efficiently with improved survival when transplanted into damaged heart tissue, which would greatly benefit patients on Earth," Xu explained in the article.

Research Report:Spaceflight alters protein levels and gene expression associated with stress response and metabolic characteristics in human cardiac spheroids

]]> Fri, 23 MAY 2025 02:09:30 AEST Los Angeles CA (SPX) Mar 30, 2025 - Sierra Space, a top-tier commercial space and defense technology company focused on leveraging space to enhance life on Earth, has deepened its collaboration with German space biotech firm Yuri. The new agreement centers on a forthcoming ScienceTaxi BioSpin mission, targeting advancements in microgravity-enabled biological research and pharmaceutical development.

The expanded contract follows the companies' initial 2022 partnership that delivered Yuri's ScienceTaxi platform to the International Space Station (ISS). Under this new phase, Sierra Space will take on end-to-end responsibilities, managing payload integration, launch logistics, operational execution in orbit, and re-entry services for Yuri's experimental payloads. This strengthened cooperation represents a notable step toward addressing infrastructure gaps in Low Earth Orbit (LEO) for in-space biotech R and D and manufacturing using Yuri's middeck lockers and specialized bioreactors.

"Our expanded partnership with Yuri aligns with our vision of making space more accessible for scientific innovation in order to ultimately benefit those on Earth," said Ken Shields, Sr. Director of Business Development at Sierra Space. "By managing Yuri's ScienceTaxi's full operational cycle, we're empowering researchers worldwide to explore new frontiers in biotechnology and medicine that could drive breakthroughs with real-world applications."

ScienceTaxi BioSpin functions as a sophisticated microgravity life sciences incubator, capable of hosting up to 38 unique experiments per mission. Its automated systems regulate temperature and collect real-time data, enabling the study of microgravity effects on diverse biological samples such as organoids, crystals, and plants. Equipped with a variable-gravity centrifuge, the system also supports comparative analyses by simulating gravitational conditions found on the Moon or Mars.

"Our partnership with Sierra Space is a strong example of how international collaboration can drive life sciences beyond Earth. As we move towards a post-ISS era, transatlantic partnerships like ours are more critical than ever, providing a reliable and sustainable pathway for commercial research in Low Earth Orbit," said Maria Birlem, CEO, Yuri GmbH. "By ensuring continued access to space for biotech innovation, we are laying the foundation for groundbreaking discoveries that will shape the future of medicine and biotechnology-both in orbit and on Earth."

The collaboration also aligns with Sierra Space's broader goals of supporting scalable and innovative platforms for space research. As new commercial space stations come online, the two companies aim to expand ScienceTaxi's role beyond the ISS, ensuring continuous access for the biotech sector to conduct pioneering research in LEO. This strategic alliance reinforces the growing momentum behind commercial biomedical research in orbit.

]]> Fri, 23 MAY 2025 02:09:30 AEST Subscribe to our daily selection of space, military, environment and energy newsletters responseText http://visitor.constantcontact.com/manage/optin/ea?v=0016gbbKsaiGSpQFojVO8ZoHw%3D%3D